Frontier Capital Management’s Revolution Medicines RVMD Stock Holding History

Frontier Capital Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.73M	Sell	51,956 -191,848	-79%	-$28M	0.09%	251
2026 Q1	$23.7M	Sell	243,804 -186,964	-43%	-$18.9M	0.24%	151
2025 Q4	$34.3M	Buy	430,768 +307,988	+251%	+$20.2M	0.36%	96
2025 Q3	$5.73M	Sell	122,780 -3,663	-3%	-$143K	0.05%	272
2025 Q2	$4.65M	Buy	126,443 +34,832	+38%	+$1.34M	0.04%	274
2025 Q1	$3.24M	Buy	+91,611	New	+$3.72M	0.04%	270
2021 Q3	–	Sell	-21,853	Closed	-$694K	–	291
2021 Q2	$694K	Sell	21,853 -649	-3%	-$22.7K	0.01%	280
2021 Q1	$1.03M	Buy	+22,502	New	+$1.01M	0.01%	266

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Frontier Capital Management's RVMD Position: Q2 2026 in Review

Frontier Capital Management reduced its Revolution Medicines (RVMD) stake by 79% in Q2 2026, selling an estimated $28M and leaving 51,956 shares worth $9.73M. The position accounts for 0.09% of the portfolio, ranked #251.

Frontier Capital Management first reported a position in RVMD in Q1 2021 and has held it in 8 quarters since. The position peaked at $34.3M in Q4 2025. 692 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Frontier Capital Management held 51,956 shares of Revolution Medicines worth $9.73M as of Q2 2026.
Frontier Capital Management sold 191,848 Revolution Medicines shares in Q2 2026, an estimated $28M.
Revolution Medicines made up 0.09% of Frontier Capital Management's portfolio in Q2 2026, its #251 holding.
Frontier Capital Management first reported a position in Revolution Medicines in Q1 2021 and has held it in 8 quarters since.
Frontier Capital Management's Revolution Medicines position peaked at $34.3M in Q4 2025.
692 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Frontier Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.